When Novo Nordisk reports earnings Wednesday morning, investors will be seeking reassurance that they haven’t overestimated ...
Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a ...
Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss medicine ...
Novo Nordisk stock faces bearish technicals, but analysts forecast nearly 46% upside. Novo inks $285 million Ascendis deal, ...
Novo Nordisk, the drug company that makes Ozempic and Wegovy ... 37% of people using a GLP-1 drug for either diabetes or ...
Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...
Fortune on MSN1d
Danish town where weight-loss wonder drug Ozempic is made suffers from the highest rates of overweight children in DenmarkA more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.
1don MSN
Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...
Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical industry regulator over the way it has ...
Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO) on Tuesday asked the U.S. Food and Drug Administration to ban compounding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback